SlideShare une entreprise Scribd logo
1  sur  38
Safety issues in assisted reproduction technology The children of assisted reproduction confront the responsible conduct of assisted reproductive technologies Obstétrique et gynécologie Faculté de médecine R D Lambert, Laval University, Québec, Canada M J Mélançon, University of Québec, Chicoutimi, Canada Unité de bioéthique Sciences humaines
Safety issues in assisted reproduction technology ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Safety issues in assisted reproduction technology ,[object Object],[object Object],[object Object]
Multiple  pregnancies.  Data ,[object Object],[object Object]
Multiple  pregnancies.  Data Number of children born alive after an IVF or an ovarian stimulation in Canada and USA   OS: Ovarian stimulation 27 665 (21.9%) 3 192 (≈9%) 15 411 (44%) 16 422 (46.9%) ≈ 2 094 ( ≈ 21.9%) ≥ 147 (7%) 994 (46%) 1014 (47%) Twins & + Triplets & + Twins Single-tons Twins  & + Triplets & + Twins Single-tons OS IVF/ICSI: 35 025 babies OS IVF/ICSI: ≥2155 babies 126 325 9 561 USA (2000) Canada (2002)
Multiple  pregnancies.  Data Frequency of health problems in IVF babies and in the general population %: frequency among all pregnancies.  1) Stromberg et al (2002). Lancet 359:461-5. 2) Hansen et al (2002). NEJM 346(10):725-30. 3) Koivurova et al (2002). Hum Reprod 17(5):1391-8. 4) Schieve et al (2002). NEJM 346(10):731-7. 5) Olivennes et al (2002). Hum Reprod Update 8(2):117-28.   6)  Calculated from Moll et al (2003). Lancet 361:309-10. Suggestive data from multiple and single pregnancies.   7)  Calculated from Maher et al (2003). J Med Genet 40:62-4. Suggestive data from multiple and single pregnancies. 8) DeBaun et al (2003). Am J Hum Genet 72:156-60. Suggestive data from multiple and single pregnancies.   0.014% 0.0033% Beckwith-Wiedemann Syndrome 7,8 0.03-.04% 0.006% Retinoblastoma 6 0.39% 0.1% Child dveloppement 1   16-28% 8.9-14% Néonatal mortality 3,5   0.39-6.6% 8.9-14% Multiple birth defects 1,3 2.6-8% 0.9-1.4% Very low birth weight (<1500g) 2,3,4 13-30% 4.6-7.3% Low birth weight ( <2500g) 2,3,4   31-32% 7-7.8% Prematurity (<37) 2,3 5.3% 1.1% Prematurity (<32) 2 0.55% 0.15% Cerebral palsy 1 All IVF babies Whole population Pathology
Multiple  pregnancies.  Data Frequency of health problems in twins and triplets conceived spontaneously or through IVF %: frequency among all pregnancies.  1)  Helmerhorst  et al (2004). « Matched studies only. 2)  Pinborg  et al (2004). NEJM 346(10):725-30. 3)  Nowak  et al (2003). Tables I, II and IV . 0.6% 0.6% Child development 39.5% 20.8% 7.6% 10.6% 15.4% 23% 43.3% Neonatal mortality 23.5% 31.9% 5.4% 10.1% 1.2% 1.1% 5-25% 3.8-10.4% Low birth weight ( <1500g)   - France - USA  28.4% 41.3% 7.8% 13.9% 1.6% 1.7% 6.8% 7.1% Prematurity (<32) - France - USA   0.4% 0.3% Cerebral palsy Triplets Twins Singletons IVF Spontaneous IVF Spontaneous IVF 3 Twins 2 Twins 1 Pathology
Multiple  pregnancies.  Data Estimation of the number of babies born  with health problems  from iatrogenic multiple pregnancies  in 2002 in Canada %:  frequency among all pregnancies. *:  <1500g. 1: n=994, see slide No 4; 2: The lowest frequency as reported in the previous slide; 3: n=147, see slide No 4; 4:  Nowak  et al ., (2003); (): No of infants who would have been affected if the incidence had been the same as in the whole population (slide No 5) 16 13 (2) 0.6% --- --- 6 (1) 0.6% Child development  98 222 (186) 10.6% 58 (13) 39.5% 105 (88) 10.6% Neonatal mortality  173 105 (19) 5% 47 (1.3) 31.9% 50 (9) 5% Very low birth weight* 236 143 (23) 6.8% 61 (1.6) 41.3% 68 (11) 6.8% Prematurity (<32 weeks) 7 8 (3) 0.4% --- --- 4 (1.5) 0.4% Cerebral palsy Total number in excess Affected infants Selected frequen-cy 2 Affected infants Selected frequen-cy 4 Affected infants Selected frequen-cy 2 IVF + OS Twins & + OS IVF triplets 3 IVF twins 1 Pathology
Multiple  pregnancies.  Data Estimation of the number of babies born  with health problems  from iatrogenic multiple pregnancies  in 2002 in USA %:  frequency among all pregnancies. *:  <1500g. 1: n=15 411, see slide No 4; 2: The lowest frequency as reported in the previous slide; 3: n=3 192, see slide No 4; 4:  Nowak  et al ., (2003); (): No of infants who would have been affected if the incidence had been the same as in the whole population (slide No 5) 215 166 (28) 0.6% --- --- 92 (15) 0.6% Child development  1696 2932 (2462) 10.6% 1245 (281) 39.5% 1634 (1372) 10.6% Neonatal mortality  2743 1383 (249) 5% 1005 (28) 31.9% 771 (139) 5% Very low birth weight* 3722 1881 (304) 6.8% 1302 (35) 41.3% 1048 (170) 6.8% Prematurity (<32) 1 107 111 (42) 0.4% --- --- 62 (23) 0.4% Cerebral palsy Total number in excess Affected infants Selected frequen-cy 2 Affected infants 7 Selected frequen-cy 4 Affected infants Selected frequen-cy 2 IVF + OS Twins & + OS IVF triplets 3 IVF twins 1 Pathology
Multiple  pregnancies.  Regulations ,[object Object],[object Object],[object Object],[object Object],[object Object]
Multiple  pregnancies.  Regulations ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Multiple  pregnancies.  Regulations ,[object Object],[object Object]
Multiple  pregnancies.  Regulations ,[object Object],[object Object],[object Object]
Multiple  pregnancies.  Regulations ,[object Object],[object Object]
Multiple  pregnancies.  Regulations ,[object Object],[object Object],[object Object],[object Object],[object Object]
Multiple  pregnancies.  Regulations ,[object Object],[object Object],[object Object]
Multiple  pregnancies.  Regulations ,[object Object],[object Object]
Multiple  pregnancies.  Regulations ,[object Object],[object Object]
[object Object],[object Object],Safety issues in assisted reproduction technology
Singleton  pregnancies.  Data ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Singleton  pregnancies.  Data * : % of all pregnancies;  1: Schieve  et al ., 2002; 2: Strömberg  et al ., 2002; 3: Hansen  et al ., 2002; 4: Koivurova  et al ., 2002; Poikkeus  et al ., 2007 2 2 0.19 2 0.09 2 Growth retardation 2.2 2 2.3 3 0.35 2 9.5 3 0.16 2 4.2 3 Birth defects 1.8 1 2.7 3 2.8 4 1.8 5 2.6 1 3 3 2.0  4 1.1 5 1.4 1 1.1 3 0.7 4 0.6 5 VLBW 1.8 1 1.7 3 1.6 4 13.2 1 7 3 4.0 4 7.3 1 4.2 3 2.5 4 LBW 1.8 4 1.6 5 2 4 1.1 5 1.1 4 0.7 5 Prematurity ≤ 32 sem 2.2 3 1.5 4 12.5 3 8.6 4 5.8 3 5.6 4 Prematurity ≤ 37 sem 2.8 2 0.38 2 0.14 2 Cerebral palsy Risk IVF General population Incidence and risks* Health problems
Singleton  pregnancies.  Data ,[object Object],[object Object],[object Object],[object Object],[object Object]
Singleton  pregnancies.  Etiology of the risks ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Singleton  pregnancies.    Etiology of the risks ,[object Object],[object Object],[object Object]
Singleton  pregnancies.    Etiology of the risks ,[object Object],[object Object],[object Object],[object Object],[object Object]
Safety issues in assisted reproduction technology. Discussion ,[object Object],[object Object],[object Object]
Evolution of the knowledge regarding the IVF babies’ health ,[object Object],[object Object]
Evolution of the knowledge regarding the IVF babies’ health ,[object Object],[object Object]
Evolution of the knowledge regarding the IVF babies’ health ,[object Object],[object Object]
Evolution of the knowledge regarding the IVF babies’ health ,[object Object],[object Object]
Evolution of ethics within time ,[object Object]
The responsible conduct of ARTs ,[object Object],[object Object],[object Object],[object Object]
The responsible conduct of ARTs ,[object Object],[object Object]
The responsible conduct of ARTs ,[object Object],[object Object],[object Object],[object Object]
Safety issues in assisted reproduction technology ,[object Object],[object Object],[object Object],[object Object]
Safety issues in assisted reproduction technology ,[object Object],[object Object]
Safety issues in assisted reproduction technology ,[object Object],[object Object]
Safety issues in assisted reproduction technology ,[object Object],[object Object]

Contenu connexe

Tendances

Intrauterine Insemination Treatment
Intrauterine Insemination TreatmentIntrauterine Insemination Treatment
Intrauterine Insemination Treatmentwaqar888
 
Ethics &amp; infertility
Ethics &amp; infertilityEthics &amp; infertility
Ethics &amp; infertilityHesham Al-Inany
 
IVF: Ways to improve pregnancy rates
IVF: Ways to improve pregnancy ratesIVF: Ways to improve pregnancy rates
IVF: Ways to improve pregnancy ratesElmar Breitbach
 
ARTIFICIAL REPRODUCTIVE TECHNIQUE
ARTIFICIAL REPRODUCTIVE TECHNIQUEARTIFICIAL REPRODUCTIVE TECHNIQUE
ARTIFICIAL REPRODUCTIVE TECHNIQUETripti Sidar
 
Intrauterine Insemination UPDATE 2018
Intrauterine Insemination UPDATE 2018 Intrauterine Insemination UPDATE 2018
Intrauterine Insemination UPDATE 2018 Lifecare Centre
 
Challenges in uterine cavity
Challenges in uterine cavityChallenges in uterine cavity
Challenges in uterine cavityHesham Al-Inany
 
Ovarian Hyperstimulation in Intrauterine Insemination
Ovarian Hyperstimulation in Intrauterine InseminationOvarian Hyperstimulation in Intrauterine Insemination
Ovarian Hyperstimulation in Intrauterine InseminationElmar Breitbach
 
Intrauterine insemination (iui)
Intrauterine insemination  (iui)Intrauterine insemination  (iui)
Intrauterine insemination (iui)Hesham Al-Inany
 
Assessment and preparation of infertile couples before icsi
Assessment and preparation of infertile couples before icsiAssessment and preparation of infertile couples before icsi
Assessment and preparation of infertile couples before icsiAhmed Mowafy
 
Recent Trends In Art (1)
Recent Trends In Art (1)Recent Trends In Art (1)
Recent Trends In Art (1)guest7f0a3a
 
Recent Trends In Art (2)
Recent Trends In Art (2)Recent Trends In Art (2)
Recent Trends In Art (2)guest7f0a3a
 
Letrozole in assisted reproduction , Prof. Usama M. Fouda
Letrozole in  assisted reproduction  , Prof. Usama M. FoudaLetrozole in  assisted reproduction  , Prof. Usama M. Fouda
Letrozole in assisted reproduction , Prof. Usama M. Foudaumfrfouda
 
WHEN TO REFER A PATIENT FOR ASSISTED REPRODUCTION ( ART ) / IVF BY DR SHASHW...
WHEN TO REFER A PATIENT FOR ASSISTED REPRODUCTION ( ART )  / IVF BY DR SHASHW...WHEN TO REFER A PATIENT FOR ASSISTED REPRODUCTION ( ART )  / IVF BY DR SHASHW...
WHEN TO REFER A PATIENT FOR ASSISTED REPRODUCTION ( ART ) / IVF BY DR SHASHW...DR SHASHWAT JANI
 

Tendances (20)

GnRH costeffectiveness
GnRH costeffectivenessGnRH costeffectiveness
GnRH costeffectiveness
 
Letrozol & reproduction
Letrozol & reproductionLetrozol & reproduction
Letrozol & reproduction
 
Techniques Of Art
Techniques Of ArtTechniques Of Art
Techniques Of Art
 
Intrauterine Insemination Treatment
Intrauterine Insemination TreatmentIntrauterine Insemination Treatment
Intrauterine Insemination Treatment
 
Ethics &amp; infertility
Ethics &amp; infertilityEthics &amp; infertility
Ethics &amp; infertility
 
IVF: Ways to improve pregnancy rates
IVF: Ways to improve pregnancy ratesIVF: Ways to improve pregnancy rates
IVF: Ways to improve pregnancy rates
 
Covid & reproduction
Covid & reproductionCovid & reproduction
Covid & reproduction
 
ARTIFICIAL REPRODUCTIVE TECHNIQUE
ARTIFICIAL REPRODUCTIVE TECHNIQUEARTIFICIAL REPRODUCTIVE TECHNIQUE
ARTIFICIAL REPRODUCTIVE TECHNIQUE
 
Intrauterine Insemination UPDATE 2018
Intrauterine Insemination UPDATE 2018 Intrauterine Insemination UPDATE 2018
Intrauterine Insemination UPDATE 2018
 
Challenges in uterine cavity
Challenges in uterine cavityChallenges in uterine cavity
Challenges in uterine cavity
 
Ovarian Hyperstimulation in Intrauterine Insemination
Ovarian Hyperstimulation in Intrauterine InseminationOvarian Hyperstimulation in Intrauterine Insemination
Ovarian Hyperstimulation in Intrauterine Insemination
 
Intrauterine Insemination
Intrauterine  InseminationIntrauterine  Insemination
Intrauterine Insemination
 
Intrauterine insemination (iui)
Intrauterine insemination  (iui)Intrauterine insemination  (iui)
Intrauterine insemination (iui)
 
Assessment and preparation of infertile couples before icsi
Assessment and preparation of infertile couples before icsiAssessment and preparation of infertile couples before icsi
Assessment and preparation of infertile couples before icsi
 
Recent Trends In Art (1)
Recent Trends In Art (1)Recent Trends In Art (1)
Recent Trends In Art (1)
 
Iui - newer concepts
Iui  - newer conceptsIui  - newer concepts
Iui - newer concepts
 
Recent Trends In Art (2)
Recent Trends In Art (2)Recent Trends In Art (2)
Recent Trends In Art (2)
 
Low Cost IVF Presentation
Low Cost IVF PresentationLow Cost IVF Presentation
Low Cost IVF Presentation
 
Letrozole in assisted reproduction , Prof. Usama M. Fouda
Letrozole in  assisted reproduction  , Prof. Usama M. FoudaLetrozole in  assisted reproduction  , Prof. Usama M. Fouda
Letrozole in assisted reproduction , Prof. Usama M. Fouda
 
WHEN TO REFER A PATIENT FOR ASSISTED REPRODUCTION ( ART ) / IVF BY DR SHASHW...
WHEN TO REFER A PATIENT FOR ASSISTED REPRODUCTION ( ART )  / IVF BY DR SHASHW...WHEN TO REFER A PATIENT FOR ASSISTED REPRODUCTION ( ART )  / IVF BY DR SHASHW...
WHEN TO REFER A PATIENT FOR ASSISTED REPRODUCTION ( ART ) / IVF BY DR SHASHW...
 

Similaire à Safety issues in assisted reproduction technology Safety issues in assisted reproduction technology

Birthdefect risk following assisted reproductive technology
 Birthdefect risk following assisted reproductive technology Birthdefect risk following assisted reproductive technology
Birthdefect risk following assisted reproductive technologymothersafe
 
Baby-making : what the new reproductive treatments mean for families & society
Baby-making : what the new reproductive treatments mean for families & society Baby-making : what the new reproductive treatments mean for families & society
Baby-making : what the new reproductive treatments mean for families & society V Somasundram
 
Normal and abnormal delivery 2018
Normal and abnormal delivery 2018Normal and abnormal delivery 2018
Normal and abnormal delivery 2018gfalakha
 
Elective Single Embryo Transfer- An Insight
Elective Single  Embryo Transfer- An InsightElective Single  Embryo Transfer- An Insight
Elective Single Embryo Transfer- An InsightKaberi Banerjee
 
Innovations & Breakthrough in IVF PART 3
Innovations & Breakthrough in IVF PART 3Innovations & Breakthrough in IVF PART 3
Innovations & Breakthrough in IVF PART 3Lifecare Centre
 
Drkenmaclean 130523003241-phpapp01
Drkenmaclean 130523003241-phpapp01Drkenmaclean 130523003241-phpapp01
Drkenmaclean 130523003241-phpapp01t7260678
 
Neonatal Jaundice,Bhutan
Neonatal Jaundice,BhutanNeonatal Jaundice,Bhutan
Neonatal Jaundice,BhutanDang Thanh Tuan
 
Art &amp; how it affects fetal morb.&amp;mort.
Art &amp; how it affects fetal morb.&amp;mort.Art &amp; how it affects fetal morb.&amp;mort.
Art &amp; how it affects fetal morb.&amp;mort.Mohamed Walaa El Deeb
 
Current Point of View in Preterm Labor Management in Albania
Current Point of View in Preterm Labor Management in AlbaniaCurrent Point of View in Preterm Labor Management in Albania
Current Point of View in Preterm Labor Management in AlbaniaRustem Celami
 
Follow up Children after Sperm Injection
Follow up Children after Sperm Injection Follow up Children after Sperm Injection
Follow up Children after Sperm Injection Yuzko Olexandr
 
cerclage for multiple pregnancy
cerclage for multiple pregnancycerclage for multiple pregnancy
cerclage for multiple pregnancyveerendrakumar cm
 
China urban birth survey
China urban birth surveyChina urban birth survey
China urban birth surveyKizito Lubano
 
ART Pregnancy - Are they different ?
ART Pregnancy -  Are they different ?ART Pregnancy -  Are they different ?
ART Pregnancy - Are they different ?Vasundhara Hospital
 
Clinical Decision Making with Machine Learning
Clinical Decision Making with Machine LearningClinical Decision Making with Machine Learning
Clinical Decision Making with Machine LearningSri Ambati
 
AN ANALYSIS OF OUTCOMES IN TWIN PREGNANCIES WITH ACTIVE FETAL SURVEILLANCE AN...
AN ANALYSIS OF OUTCOMES IN TWIN PREGNANCIES WITH ACTIVE FETAL SURVEILLANCE AN...AN ANALYSIS OF OUTCOMES IN TWIN PREGNANCIES WITH ACTIVE FETAL SURVEILLANCE AN...
AN ANALYSIS OF OUTCOMES IN TWIN PREGNANCIES WITH ACTIVE FETAL SURVEILLANCE AN...Apollo Hospitals
 
Regionalization of Perinatal Care: US Experience
Regionalization of Perinatal Care: US ExperienceRegionalization of Perinatal Care: US Experience
Regionalization of Perinatal Care: US ExperienceMCH-org-ua
 
In Vitro Fertilisation
In Vitro FertilisationIn Vitro Fertilisation
In Vitro Fertilisationtomlewis981
 

Similaire à Safety issues in assisted reproduction technology Safety issues in assisted reproduction technology (20)

Birthdefect risk following assisted reproductive technology
 Birthdefect risk following assisted reproductive technology Birthdefect risk following assisted reproductive technology
Birthdefect risk following assisted reproductive technology
 
Professor Soo Downe
Professor Soo DowneProfessor Soo Downe
Professor Soo Downe
 
Baby-making : what the new reproductive treatments mean for families & society
Baby-making : what the new reproductive treatments mean for families & society Baby-making : what the new reproductive treatments mean for families & society
Baby-making : what the new reproductive treatments mean for families & society
 
Normal and abnormal delivery 2018
Normal and abnormal delivery 2018Normal and abnormal delivery 2018
Normal and abnormal delivery 2018
 
Elective Single Embryo Transfer- An Insight
Elective Single  Embryo Transfer- An InsightElective Single  Embryo Transfer- An Insight
Elective Single Embryo Transfer- An Insight
 
Innovations & Breakthrough in IVF PART 3
Innovations & Breakthrough in IVF PART 3Innovations & Breakthrough in IVF PART 3
Innovations & Breakthrough in IVF PART 3
 
Drkenmaclean 130523003241-phpapp01
Drkenmaclean 130523003241-phpapp01Drkenmaclean 130523003241-phpapp01
Drkenmaclean 130523003241-phpapp01
 
Neonatal Jaundice,Bhutan
Neonatal Jaundice,BhutanNeonatal Jaundice,Bhutan
Neonatal Jaundice,Bhutan
 
Art &amp; how it affects fetal morb.&amp;mort.
Art &amp; how it affects fetal morb.&amp;mort.Art &amp; how it affects fetal morb.&amp;mort.
Art &amp; how it affects fetal morb.&amp;mort.
 
Current Point of View in Preterm Labor Management in Albania
Current Point of View in Preterm Labor Management in AlbaniaCurrent Point of View in Preterm Labor Management in Albania
Current Point of View in Preterm Labor Management in Albania
 
Follow up Children after Sperm Injection
Follow up Children after Sperm Injection Follow up Children after Sperm Injection
Follow up Children after Sperm Injection
 
cerclage for multiple pregnancy
cerclage for multiple pregnancycerclage for multiple pregnancy
cerclage for multiple pregnancy
 
Webinar: Strong Start for Mothers and Newborns - Reducing Early Elective Deli...
Webinar: Strong Start for Mothers and Newborns - Reducing Early Elective Deli...Webinar: Strong Start for Mothers and Newborns - Reducing Early Elective Deli...
Webinar: Strong Start for Mothers and Newborns - Reducing Early Elective Deli...
 
China urban birth survey
China urban birth surveyChina urban birth survey
China urban birth survey
 
ART Pregnancy - Are they different ?
ART Pregnancy -  Are they different ?ART Pregnancy -  Are they different ?
ART Pregnancy - Are they different ?
 
Clinical Decision Making with Machine Learning
Clinical Decision Making with Machine LearningClinical Decision Making with Machine Learning
Clinical Decision Making with Machine Learning
 
AN ANALYSIS OF OUTCOMES IN TWIN PREGNANCIES WITH ACTIVE FETAL SURVEILLANCE AN...
AN ANALYSIS OF OUTCOMES IN TWIN PREGNANCIES WITH ACTIVE FETAL SURVEILLANCE AN...AN ANALYSIS OF OUTCOMES IN TWIN PREGNANCIES WITH ACTIVE FETAL SURVEILLANCE AN...
AN ANALYSIS OF OUTCOMES IN TWIN PREGNANCIES WITH ACTIVE FETAL SURVEILLANCE AN...
 
IJMPR43109-477-481.docx
IJMPR43109-477-481.docxIJMPR43109-477-481.docx
IJMPR43109-477-481.docx
 
Regionalization of Perinatal Care: US Experience
Regionalization of Perinatal Care: US ExperienceRegionalization of Perinatal Care: US Experience
Regionalization of Perinatal Care: US Experience
 
In Vitro Fertilisation
In Vitro FertilisationIn Vitro Fertilisation
In Vitro Fertilisation
 

Plus de MedicineAndHealth14

Preop Assessment Periop Management
Preop Assessment Periop ManagementPreop Assessment Periop Management
Preop Assessment Periop ManagementMedicineAndHealth14
 
www.triz.hk/icoiappt/icoia010601.ppt www.triz.hk/icoiappt/icoia010601.ppt
www.triz.hk/icoiappt/icoia010601.ppt 	 www.triz.hk/icoiappt/icoia010601.pptwww.triz.hk/icoiappt/icoia010601.ppt 	 www.triz.hk/icoiappt/icoia010601.ppt
www.triz.hk/icoiappt/icoia010601.ppt www.triz.hk/icoiappt/icoia010601.pptMedicineAndHealth14
 
Design of a medical simulator for subcutaneous contraceptive implant insertio...
Design of a medical simulator for subcutaneous contraceptive implant insertio...Design of a medical simulator for subcutaneous contraceptive implant insertio...
Design of a medical simulator for subcutaneous contraceptive implant insertio...MedicineAndHealth14
 
Obesity: The Bariatric Challenge Obesity: The Bariatric Challenge
Obesity: The Bariatric Challenge 	 Obesity: The Bariatric ChallengeObesity: The Bariatric Challenge 	 Obesity: The Bariatric Challenge
Obesity: The Bariatric Challenge Obesity: The Bariatric ChallengeMedicineAndHealth14
 
PEPTIDES AS BIOTHERAPEUTIC TOOLS PEPTIDES AS BIOTHERAPEUTIC TOOLS
PEPTIDES AS BIOTHERAPEUTIC TOOLS 	 PEPTIDES AS BIOTHERAPEUTIC TOOLSPEPTIDES AS BIOTHERAPEUTIC TOOLS 	 PEPTIDES AS BIOTHERAPEUTIC TOOLS
PEPTIDES AS BIOTHERAPEUTIC TOOLS PEPTIDES AS BIOTHERAPEUTIC TOOLSMedicineAndHealth14
 

Plus de MedicineAndHealth14 (20)

Diabetic eye disease
Diabetic eye diseaseDiabetic eye disease
Diabetic eye disease
 
Womenseyehealth
WomenseyehealthWomenseyehealth
Womenseyehealth
 
Retinoblastoma
RetinoblastomaRetinoblastoma
Retinoblastoma
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
 
Eye
EyeEye
Eye
 
Radical Neck Dissection
Radical Neck DissectionRadical Neck Dissection
Radical Neck Dissection
 
Entgr Tonsillectomy
Entgr TonsillectomyEntgr Tonsillectomy
Entgr Tonsillectomy
 
Preop Assessment Periop Management
Preop Assessment Periop ManagementPreop Assessment Periop Management
Preop Assessment Periop Management
 
Iodine
IodineIodine
Iodine
 
Deep Neck Infections
Deep Neck InfectionsDeep Neck Infections
Deep Neck Infections
 
Passive Smoking and Health
Passive Smoking and HealthPassive Smoking and Health
Passive Smoking and Health
 
www.triz.hk/icoiappt/icoia010601.ppt www.triz.hk/icoiappt/icoia010601.ppt
www.triz.hk/icoiappt/icoia010601.ppt 	 www.triz.hk/icoiappt/icoia010601.pptwww.triz.hk/icoiappt/icoia010601.ppt 	 www.triz.hk/icoiappt/icoia010601.ppt
www.triz.hk/icoiappt/icoia010601.ppt www.triz.hk/icoiappt/icoia010601.ppt
 
Surgery Block Evaluation
Surgery Block EvaluationSurgery Block Evaluation
Surgery Block Evaluation
 
Cough In The Elderly
Cough In The ElderlyCough In The Elderly
Cough In The Elderly
 
Emergency Contraception
Emergency ContraceptionEmergency Contraception
Emergency Contraception
 
Design of a medical simulator for subcutaneous contraceptive implant insertio...
Design of a medical simulator for subcutaneous contraceptive implant insertio...Design of a medical simulator for subcutaneous contraceptive implant insertio...
Design of a medical simulator for subcutaneous contraceptive implant insertio...
 
Oral Pathology
Oral PathologyOral Pathology
Oral Pathology
 
Obesity: The Bariatric Challenge Obesity: The Bariatric Challenge
Obesity: The Bariatric Challenge 	 Obesity: The Bariatric ChallengeObesity: The Bariatric Challenge 	 Obesity: The Bariatric Challenge
Obesity: The Bariatric Challenge Obesity: The Bariatric Challenge
 
PEPTIDES AS BIOTHERAPEUTIC TOOLS PEPTIDES AS BIOTHERAPEUTIC TOOLS
PEPTIDES AS BIOTHERAPEUTIC TOOLS 	 PEPTIDES AS BIOTHERAPEUTIC TOOLSPEPTIDES AS BIOTHERAPEUTIC TOOLS 	 PEPTIDES AS BIOTHERAPEUTIC TOOLS
PEPTIDES AS BIOTHERAPEUTIC TOOLS PEPTIDES AS BIOTHERAPEUTIC TOOLS
 
Diabetes
DiabetesDiabetes
Diabetes
 

Dernier

PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 

Dernier (20)

PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 

Safety issues in assisted reproduction technology Safety issues in assisted reproduction technology

  • 1. Safety issues in assisted reproduction technology The children of assisted reproduction confront the responsible conduct of assisted reproductive technologies Obstétrique et gynécologie Faculté de médecine R D Lambert, Laval University, Québec, Canada M J Mélançon, University of Québec, Chicoutimi, Canada Unité de bioéthique Sciences humaines
  • 2.
  • 3.
  • 4.
  • 5. Multiple pregnancies. Data Number of children born alive after an IVF or an ovarian stimulation in Canada and USA OS: Ovarian stimulation 27 665 (21.9%) 3 192 (≈9%) 15 411 (44%) 16 422 (46.9%) ≈ 2 094 ( ≈ 21.9%) ≥ 147 (7%) 994 (46%) 1014 (47%) Twins & + Triplets & + Twins Single-tons Twins & + Triplets & + Twins Single-tons OS IVF/ICSI: 35 025 babies OS IVF/ICSI: ≥2155 babies 126 325 9 561 USA (2000) Canada (2002)
  • 6. Multiple pregnancies. Data Frequency of health problems in IVF babies and in the general population %: frequency among all pregnancies. 1) Stromberg et al (2002). Lancet 359:461-5. 2) Hansen et al (2002). NEJM 346(10):725-30. 3) Koivurova et al (2002). Hum Reprod 17(5):1391-8. 4) Schieve et al (2002). NEJM 346(10):731-7. 5) Olivennes et al (2002). Hum Reprod Update 8(2):117-28. 6) Calculated from Moll et al (2003). Lancet 361:309-10. Suggestive data from multiple and single pregnancies. 7) Calculated from Maher et al (2003). J Med Genet 40:62-4. Suggestive data from multiple and single pregnancies. 8) DeBaun et al (2003). Am J Hum Genet 72:156-60. Suggestive data from multiple and single pregnancies. 0.014% 0.0033% Beckwith-Wiedemann Syndrome 7,8 0.03-.04% 0.006% Retinoblastoma 6 0.39% 0.1% Child dveloppement 1 16-28% 8.9-14% Néonatal mortality 3,5 0.39-6.6% 8.9-14% Multiple birth defects 1,3 2.6-8% 0.9-1.4% Very low birth weight (<1500g) 2,3,4 13-30% 4.6-7.3% Low birth weight ( <2500g) 2,3,4 31-32% 7-7.8% Prematurity (<37) 2,3 5.3% 1.1% Prematurity (<32) 2 0.55% 0.15% Cerebral palsy 1 All IVF babies Whole population Pathology
  • 7. Multiple pregnancies. Data Frequency of health problems in twins and triplets conceived spontaneously or through IVF %: frequency among all pregnancies. 1) Helmerhorst et al (2004). « Matched studies only. 2) Pinborg et al (2004). NEJM 346(10):725-30. 3) Nowak et al (2003). Tables I, II and IV . 0.6% 0.6% Child development 39.5% 20.8% 7.6% 10.6% 15.4% 23% 43.3% Neonatal mortality 23.5% 31.9% 5.4% 10.1% 1.2% 1.1% 5-25% 3.8-10.4% Low birth weight ( <1500g) - France - USA 28.4% 41.3% 7.8% 13.9% 1.6% 1.7% 6.8% 7.1% Prematurity (<32) - France - USA 0.4% 0.3% Cerebral palsy Triplets Twins Singletons IVF Spontaneous IVF Spontaneous IVF 3 Twins 2 Twins 1 Pathology
  • 8. Multiple pregnancies. Data Estimation of the number of babies born with health problems from iatrogenic multiple pregnancies in 2002 in Canada %: frequency among all pregnancies. *: <1500g. 1: n=994, see slide No 4; 2: The lowest frequency as reported in the previous slide; 3: n=147, see slide No 4; 4: Nowak et al ., (2003); (): No of infants who would have been affected if the incidence had been the same as in the whole population (slide No 5) 16 13 (2) 0.6% --- --- 6 (1) 0.6% Child development 98 222 (186) 10.6% 58 (13) 39.5% 105 (88) 10.6% Neonatal mortality 173 105 (19) 5% 47 (1.3) 31.9% 50 (9) 5% Very low birth weight* 236 143 (23) 6.8% 61 (1.6) 41.3% 68 (11) 6.8% Prematurity (<32 weeks) 7 8 (3) 0.4% --- --- 4 (1.5) 0.4% Cerebral palsy Total number in excess Affected infants Selected frequen-cy 2 Affected infants Selected frequen-cy 4 Affected infants Selected frequen-cy 2 IVF + OS Twins & + OS IVF triplets 3 IVF twins 1 Pathology
  • 9. Multiple pregnancies. Data Estimation of the number of babies born with health problems from iatrogenic multiple pregnancies in 2002 in USA %: frequency among all pregnancies. *: <1500g. 1: n=15 411, see slide No 4; 2: The lowest frequency as reported in the previous slide; 3: n=3 192, see slide No 4; 4: Nowak et al ., (2003); (): No of infants who would have been affected if the incidence had been the same as in the whole population (slide No 5) 215 166 (28) 0.6% --- --- 92 (15) 0.6% Child development 1696 2932 (2462) 10.6% 1245 (281) 39.5% 1634 (1372) 10.6% Neonatal mortality 2743 1383 (249) 5% 1005 (28) 31.9% 771 (139) 5% Very low birth weight* 3722 1881 (304) 6.8% 1302 (35) 41.3% 1048 (170) 6.8% Prematurity (<32) 1 107 111 (42) 0.4% --- --- 62 (23) 0.4% Cerebral palsy Total number in excess Affected infants Selected frequen-cy 2 Affected infants 7 Selected frequen-cy 4 Affected infants Selected frequen-cy 2 IVF + OS Twins & + OS IVF triplets 3 IVF twins 1 Pathology
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21. Singleton pregnancies. Data * : % of all pregnancies; 1: Schieve et al ., 2002; 2: Strömberg et al ., 2002; 3: Hansen et al ., 2002; 4: Koivurova et al ., 2002; Poikkeus et al ., 2007 2 2 0.19 2 0.09 2 Growth retardation 2.2 2 2.3 3 0.35 2 9.5 3 0.16 2 4.2 3 Birth defects 1.8 1 2.7 3 2.8 4 1.8 5 2.6 1 3 3 2.0 4 1.1 5 1.4 1 1.1 3 0.7 4 0.6 5 VLBW 1.8 1 1.7 3 1.6 4 13.2 1 7 3 4.0 4 7.3 1 4.2 3 2.5 4 LBW 1.8 4 1.6 5 2 4 1.1 5 1.1 4 0.7 5 Prematurity ≤ 32 sem 2.2 3 1.5 4 12.5 3 8.6 4 5.8 3 5.6 4 Prematurity ≤ 37 sem 2.8 2 0.38 2 0.14 2 Cerebral palsy Risk IVF General population Incidence and risks* Health problems
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.